Empagliflozin may not exhibit clinical or mortality benefit in COVID-19 patients Jacinthlyn Sylvia5 Dec 2023 10:15 AM ISTThe RECOVERY trial has concluded that empagliflozin, a drug proposed for its anti-inflammatory and metabolic effects, does not provide substantial...
Link between COVID-19 vaccination and breakthrough infections, complications in cancer patients Isra Zaman2 Jan 2023 9:15 AM ISTPatients with cancer are known to have increased risk of COVID-19 complications, including death.In a recent study, published in JAMA Oncology, the...
Cardiologists at G.B. Pant find rare link between COVID-19 cytokine storm and ARVD. dr. Abhimanyu Uppal4 Aug 2021 9:41 AM ISTA team of cardiologists led by head of Cardiology department at G.B. Pant Hospital, New Delhi- Dr. Saibal Mukhpadhyay, have shown a unique...
Hypercoagulable state in COVID blocks two coronary stents simultaneously, EHJ report. dr. Abhimanyu Uppal10 Jun 2021 10:00 AM ISTCoronavirus disease 2019 (COVID-19) is associated with hypercoagulability and a high rate of thrombosis. Authors Mareau et al have reported an...
NSAIDs Don't Worsen COVID 19 Outcomes, Study resolves controversy Dr Kartikeya Kohli11 May 2021 11:45 AM ISTEarly in the pandemic, it was suggested that pre-existing use of non-steroidal anti-inflammatory drugs (NSAIDs) could lead to increased disease...
Optimum blood sugar control improves outcomes in COVID-19 patients: Study Dr. Kamal Kant Kohli29 May 2020 11:12 PM ISTIt is well known that poor blood sugar control in patients with Covid 19 Infection is linked to poor outcomes. One in ten COVID-19 patients with...
